Explore more publications!
Health Monitor Monaco
Got News to Share?

Health Monitor Monaco: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Monaco.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 12, 2026

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
January 12, 2026

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)

Indeterminate GlobeNewswire
PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator® Device for Non-Invasive Treatment of ALS
January 12, 2026

PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator® Device for Non-Invasive Treatment of ALS

Indeterminate GlobeNewswire
Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
January 12, 2026

Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy

Indeterminate GlobeNewswire
Teladoc Health Launches Enhanced 24/7 Care Service
January 12, 2026

Teladoc Health Launches Enhanced 24/7 Care Service

Indeterminate GlobeNewswire
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results
January 12, 2026

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

Indeterminate GlobeNewswire
Communiqué de presse : Teizeild de Sanofi approuvé dans l'UE pour les patients atteints de diabète de type 1 de stade 2
January 12, 2026

Communiqué de presse : Teizeild de Sanofi approuvé dans l'UE pour les patients atteints de diabète de type 1 de stade 2

Indeterminate GlobeNewswire
Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes
January 12, 2026

Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes

Indeterminate GlobeNewswire
Publication relating to transparency notification
January 12, 2026

Publication relating to transparency notification

Indeterminate GlobeNewswire
argenx Highlights 2026 Strategic Priorities
January 12, 2026

argenx Highlights 2026 Strategic Priorities

Indeterminate GlobeNewswire
Publication relative à une notification de transparence
January 12, 2026

Publication relative à une notification de transparence

Indeterminate GlobeNewswire
Healthy Gut Announces Updated Holozyme Formula Addressing Digestive Sensitivity to Fructan-Containing Foods
January 12, 2026

Healthy Gut Announces Updated Holozyme Formula Addressing Digestive Sensitivity to Fructan-Containing Foods

Indeterminate GlobeNewswire
Expert Dermatologist Dr. Hannah Pederson, MD of Boulder/Niwot, Explains Why Skincare Routines Might Trigger Breakouts for HelloNation
January 12, 2026

Expert Dermatologist Dr. Hannah Pederson, MD of Boulder/Niwot, Explains Why Skincare Routines Might Trigger Breakouts for HelloNation

Indeterminate GlobeNewswire
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
January 12, 2026

FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation

Indeterminate GlobeNewswire
Paul Chua Joins Health-ISAC® as Asia Pacific Operations Director
January 12, 2026

Paul Chua Joins Health-ISAC® as Asia Pacific Operations Director

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions